Common Stock, Shares, Outstanding of Protalix BioTherapeutics, Inc. from 31 Dec 2010 to 31 Dec 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Protalix BioTherapeutics, Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2010 to 31 Dec 2024.
  • Protalix BioTherapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending 31 Dec 2024 was 75,850,275, a 4% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Protalix BioTherapeutics, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 75,850,275 +2,898,151 +4% 31 Dec 2024 10-K 17 Mar 2025 2024 FY
Q4 2023 72,952,124 +19,161,957 +36% 31 Dec 2023 10-K 17 Mar 2025 2024 FY
Q4 2022 53,790,167 +8,233,520 +18% 31 Dec 2022 10-K 14 Mar 2024 2023 FY
Q4 2021 45,556,647 +10,791,367 +31% 31 Dec 2021 10-K 27 Feb 2023 2022 FY
Q4 2020 34,765,280 +19,927,067 +134% 31 Dec 2020 10-K 31 Mar 2022 2021 FY
Q4 2019 14,838,213 0 0% 31 Dec 2019 10-K 30 Mar 2021 2020 FY
Q4 2018 14,838,213 -128,890,584 -90% 31 Dec 2018 10-K 12 Mar 2020 2019 FY
Q4 2017 143,728,797 +19,594,712 +16% 31 Dec 2017 10-K 18 Mar 2019 2018 FY
Q4 2016 124,134,085 +24,333,688 +24% 31 Dec 2016 10-K 06 Mar 2018 2017 FY
Q4 2015 99,800,397 +6,196,578 +6.6% 31 Dec 2015 10-K 16 Mar 2017 2016 FY
Q4 2014 93,603,819 +52,721 +0.06% 31 Dec 2014 10-K 08 Mar 2016 2015 FY
Q4 2013 93,551,098 +61,289 +0.07% 31 Dec 2013 10-K 12 Mar 2015 2014 FY
Q4 2012 93,489,809 +7,859,652 +9.2% 31 Dec 2012 10-K 13 Mar 2014 2013 FY
Q4 2011 85,630,157 +4,381,685 +5.4% 31 Dec 2011 10-K 28 Feb 2013 2012 FY
Q4 2010 81,248,472 31 Dec 2010 10-K 27 Feb 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.